United States· US:68462-405_d202f375-08c4-42da-bd96-2b62d7ebe7e8
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
A medicinal product containing aspirin; dipyridamole, registered in United States by Glenmark Pharmaceuticals Inc., USA.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ASPIRIN; DIPYRIDAMOLE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1168462-405-30
- ndc1168462-405-60
- ndc11684624053030 CAPSULE in 1 BOTTLE (68462-405-30)
- ndc11684624056060 CAPSULE in 1 BOTTLE (68462-405-60)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aspirin; dipyridamole in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAsasantin Retard capsulesDowelhurst Ltd
- FinlandAsasantin RetardBoehringer Ingelheim International GmbH
- NetherlandsDipyridamol/Acetylsalicylzuur Sandoz 200/25 mg, capsules met gereguleerde afgifte, hardSandoz B.V.
- NorwayDiprasorinOrion Corporation - Espoo
- SwedenDiprasorin 200 mg/25 mg Kapsel med modifierad frisättning, hårdOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Denmark · Orisantin
- Finland · Orisantin
- United Kingdom (Northern Ireland) · Svelux
- Netherlands · Dipyridamol/Acetylsalicylzuur Sandoz
- Norway · Diprasorin
- Sweden · Diprasorin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d2592a1a-e534-4903-8f2a-ec4ec50ddc03 GET /v1/drugs/d2592a1a-e534-4903-8f2a-ec4ec50ddc03?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "25; 200",
"substance": "ASPIRIN; DIPYRIDAMOLE",
"productndc": "68462-405",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA210318",
"marketing_category": "ANDA"
}See everything about aspirin; dipyridamole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.